Double-stranded ribonucleic acid targeting PD-l1

MYPI2026000549A0Undetermined Publication Date: 2025-02-04CHIA TAI TIANQING PHARMA GRP CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026000549
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-01-26
Filing Date
2024-08-02
Publication Date
2025-02-04
Patent Text Reader

Abstract

Provided are a small interfering ribonucleic acid targeting PD-L1, a pharmaceutically acceptable salt thereof, or a ligand conjugate thereof. Further provided are a pharmaceutical composition containing the small interfering ribonucleic acid, the pharmaceutically acceptable salt thereof, or the ligand conjugate thereof, and a therapeutic use of the small interfering ribonucleic acid, the pharmaceutically acceptable salt thereof, or the ligand conjugate thereof.
Need to check novelty before this filing date? Find Prior Art